Geron
GERN
#7199
Rank
A$0.88 B
Marketcap
A$1.37
Share price
-7.86%
Change (1 day)
-17.57%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -A$28.61 Million

According to Geron's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$76.39 Million, an increase over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$28.61 Million-62.55%
2025 -A$76.39 Million-67.42%
2024 -A$0.24 Billion-11.23%
2023 -A$0.27 Billion30.22%
2022 -A$0.21 Billion20.15%
2021 -A$0.17 Billion50.08%
2020 -A$0.12 Billion4.46%
2019 -A$0.11 Billion130.68%
2018 -A$46.69 Million8.84%
2017 -A$42.9 Million-3.08%
2016 -A$44.26 Million-22080.6%
2015 A$0.2 M-100.38%
2014 -A$53.47 Million-7.14%
2013 -A$57.58 Million
2011 -A$0.14 Billion19.04%
2010 -A$0.12 Billion8.45%
2009 -A$0.11 Billion-2.51%
2008 -A$0.11 Billion14.65%
2007 -A$94.41 Million32.68%
2006 -A$71.16 Million25.59%
2005 -A$56.66 Million4.36%
2004 -A$54.29 Million19.73%
2003 -A$45.35 Million-15.46%
2002 -A$53.64 Million1.94%
2001 -A$52.62 Million33.59%
2000 -A$39.39 Million27.53%
1999 -A$30.89 Million63.13%
1998 -A$18.94 Million15.6%
1997 -A$16.38 Million-10.66%
1996 -A$18.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-A$3.81 Billion 13,205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$1.19 B-4,282.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$0.11 Billion 263.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.37 B-1,414.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$24.82 Million-13.22%๐Ÿ‡บ๐Ÿ‡ธ USA